Article
TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
Journal of virology - 1 Feb 2015
Wu Fan, Ourmanov Ilnour, Riddick Nadeene, Matsuda Kenta, Whitted Sonya, Plishka Ronald J, Buckler-White Alicia, Starost Matthew F, Hirsch Vanessa M
Abstract excerpt
UNLABELLED: Tripartite motif-containing protein 5α (TRIM5α) is considered to be a potential target for cell-based gene modification therapy against human immunodeficiency virus type 1 (HIV-1) infection. In the present study, we used a relevant rhesus macaque model of infection with simian immunodeficiency virus from sooty mangabey (SIVsm) to evaluate the effect of TRIM5α restriction on clinical outcome. For...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
